Brief: Kancera Q4 operating loss widens to SEK 6.5 million

Novakand Pharma AB

21/02/2017 07:31

Feb 21 (Reuters) - Kancera AB  KANC.ST : 
    * Q4 operating loss 6.5 million Swedish crowns ($725,090) versus loss 5.9 million crowns 
year ago 
 
Source text for Eikon:  ID:nWkr5jhhK0  
Further company coverage:  KANC.ST  
 
($1 = 8.9644 Swedish crowns) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))